drugset / Trial / NCT01044004

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

NCT01044004

RandomizedSingle-groupDouble-blindTreatment

Summary

To determine whether armodafinil is more effective than placebo in reducing fatigue.

Timeline

Start
2010-03
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Armodafinil Small molecule 150 mg